Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1638 of 6351
-
Dragon boats vs. home workouts: which boosts breast cancer recovery?
Symptom relief Recruiting nowInvestigators plans to conduct a randomized, open, single center clinical study of Dragon Boat Race versus family unsupervised training to improve the physical function and quality of life in breast cancer patients to compare the effects of organized and supervised short-term dra…
Phase 2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Symptom relief
Last updated Jun 26, 2026 14:51 UTC
-
New hope for teens with severe skin disease: drug trial launches
Disease control OngoingThe purpose of the study is to assess the PK of bimekizumab following subcutaneous (sc) administration in study participants with moderate to severe hidradenitis suppurativa (HS)
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Virus therapy joins Chemo-Radiation in fight against rectal cancer
Disease control Recruiting nowThe FORTRESS trial (NG-350A-03) is an open-label, single-arm, and multicentre trial of NG-350A in combination with chemoradiotherapy (CRT) in adult patients with locally advanced rectal cancer (LARC) and at least one risk factor for local or distant recurrence.
Phase 1 • Sponsor: Akamis Bio • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Engineered T-Cells take on tough blood cancers in first human trial
Disease control Recruiting nowThis is a first in human, multi center, open label, phase 1/1b study to evaluate the safety and preliminary efficacy of CER-1236 in patients with relapsed/refractory (R/R), measurable residual disease (MRD) positive acute myeloid leukemia (AML), or TP53mut disease.
Phase 1 • Sponsor: CERo Therapeutics Holdings, Inc. • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can a Mother-Daughter workshop cut HIV rates in teen girls?
Prevention OngoingThe proposed hybrid effectiveness-implementation study will systematically adapt the Informed, Motivated, Aware, Responsible Adolescent Girls and Adults (IMARA) curriculum that was previously adapted for South Africa (IMARA-SA) to use in Zambia (will be renamed Zambian Informed, …
Sponsor: Centre for Infectious Disease Research in Zambia • Aim: Prevention
Last updated Jun 27, 2026 14:01 UTC
-
Smartphone Check-Ins could boost TB treatment success
Disease control OngoingThe gold standard for tuberculosis (TB) treatment support requires directly observed therapy (DOT), which means a trained health worker observes the patient swallow each dose of medication every day for 2 months. Despite the practice of DOT in Malaysia, 1 in 20 patients are loss-…
Sponsor: University of Malaya • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Can a daily probiotic boost metabolic health and body confidence?
Symptom relief CompletedThis study evaluates the effects of the Love Wellness supplement Hello Burn Activate on supporting metabolic health in adult females. The 12-week, single-arm, open-label, virtual trial will enroll 40 female participants aged 25-45 who are experiencing challenges with healthy weig…
Sponsor: Love Wellness • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Can a gentle energy device turn down fibromyalgia pain?
Symptom relief CompletedA total of 46 patients aged 18-65 years diagnosed with fibromyalgia according to the 2016 ACR criteria, whose most painful region was axial (neck, back, or lower back), were included in the study and randomly assigned upon admission into treatment ($n=23$) and sham control ($n=23…
Sponsor: Ankara City Hospital Bilkent • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
Could a simple blood test reveal your Baby's blood type?
Knowledge-focused OngoingThe purpose of this research is to collect blood samples and data from pregnant women who are Rh negative. The blood will be used for the future research and the development of non-invasive prenatal tests to identify Rh blood type status of the baby during pregnancy.
Sponsor: Devyser Inc. • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Could a simple blood test spare lung cancer patients from chemo?
Knowledge-focused Recruiting nowIt is a prospective, multicenter, randomized controlled trial to investigate the predictive value of MRD on adjuvant therapy. Stage IA2-II resected NSCLC patients will undergo two-round MRD tests after surgery, first in 3-7 days and second in 1 month after surgery. And patients w…
Sponsor: Peking University Cancer Hospital & Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Nerve zap could unclog heart failure lungs
Symptom relief Recruiting nowHeart failure (HF) affects more than 6 million adults in the U.S. alone, with increasing prevalence. Cardiovascular congestion with resultant limitation in physical activity is the hallmark of chronic and decompensated HF. The current HF physiologic model suggests that congestion…
Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Could a blood pressure cuff boost stroke recovery? trial tests the idea
Disease control Stopped earlyThe primary purpose of this study is to examine whether remote ischemic treatment can better the 90 - day neurological outcomes in acute ischemic stroke patients having severe stenosis or occlusion of anterior intracranial circulation vessels.
Sponsor: The First Affiliated Hospital of University of Science and Technology of China • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
One visit, two shots: study tests combining RSV and shingles vaccines
Vaccine CompletedThis purpose of this phase 3 multicenter, parallel-group, open-label study is to learn about the safety, tolerability, and immunogenicity of RSVpreF and HZ/su vaccine when given together in adults 50 years of age and older.
Phase 3 • Sponsor: Pfizer • Aim: Vaccine
Last updated Jun 27, 2026 07:56 UTC
-
New study aims to prevent brain damage in newborns by decoding heart rate patterns
Knowledge-focused Recruiting nowSevere neonatal acidosis is an identified risk factor for neonatal encephalopathies and severe neurological sequelae such as cerebral palsy. While intrapartum origin of such deterioration is rare (approximately 20% of adverse outcomes in term infants), screening for hypoxia that …
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
New study tracks safety of VYLOY in everyday cancer care
Disease control Recruiting nowThis study is for people in South Korea who have cancer in or around the stomach (gastric cancer) or cancer where the food pipe (esophagus) joins the stomach, called gastroesophageal junction (GEJ) cancer. Their cancer is locally advanced, unresectable, or metastatic. Locally adv…
Sponsor: Astellas Pharma Korea, Inc. • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New depression drug LV232 enters Mid-Stage trial
Symptom relief Recruiting nowThis multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-finding Phase II clinical trial aimed to determine the optimal dose of LV232 capsules for treating MDD, evaluate preliminary efficacy and safety, and provide a basis for Phase III trial design an…
Phase 2 • Sponsor: Vigonvita Life Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Blood Test-Guided dosing may boost depression treatment in kids and adults
Disease control Recruiting nowDepression in childhood and adolescence is a serious and increasing public-health problem associated with profound short- and long-term consequences, including impaired social and educational functioning, increased risk of somatic illness and substance use, and elevated mortality…
Phase 4 • Sponsor: Poznan University of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New obesity drug BGM0504 takes on tirzepatide in Head-to-Head trial
Disease control Recruiting nowTo evaluate the efficacy and safety of BGM0504 compared with Tirzepatide in adult participants who have obesity without diabetes after 26 weeks of treatment.
Phase 2 • Sponsor: BrightGene Bio-Medical Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New robot could improve endometrial cancer surgery
Disease control Recruiting nowProspective Multicenter Observational Study The study involves the consecutive inclusion of every patient with endometrial cancer undergoing staging surgical treatment using a robotic approach with the da Vinci SP platform.
Sponsor: National Cancer Institute, Naples • Aim: Disease control
Last updated Jun 26, 2026 18:49 UTC
-
New implant offers hope for stubborn back pain sufferers
Disease control CompletedThe goal of this observational study is to learn if Nevro1 Sacroiliac Transfixing and Fusion System can treat sacroiliac joint dysfunction in males or females over 21. The main questions it aims to answer is what percentage of patients have clinically important pain relief with n…
Sponsor: Nevro Corp • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC